Paradigm Biopharmaceuticals (Paradigm Biopharmaceuticals) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Paradigm Biopharmaceuticals Days Payable?

Paradigm Biopharmaceuticals's average Accounts Payable for the six months ended in Dec. 2023 was $7.42 Mil. Paradigm Biopharmaceuticals's Cost of Goods Sold for the six months ended in Dec. 2023 was $0.00 Mil.

The historical rank and industry rank for Paradigm Biopharmaceuticals's Days Payable or its related term are showing as below:

PBIGF' s Days Payable Range Over the Past 10 Years
Min: 14114.55 Med: 15302.12 Max: 396135.61
Current: 396135.61

During the past 8 years, Paradigm Biopharmaceuticals's highest Days Payable was 396135.61. The lowest was 14114.55. And the median was 15302.12.

PBIGF's Days Payable is ranked better than
99.59% of 724 companies
in the Biotechnology industry
Industry Median: 148.12 vs PBIGF: 396135.61

Paradigm Biopharmaceuticals's Days Payable declined from Dec. 2022 (259,223.00) to Dec. 2023 (0.00). It may suggest that Paradigm Biopharmaceuticals accelerated paying its suppliers.

Paradigm Biopharmaceuticals Days Payable Historical Data

The historical data trend for Paradigm Biopharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paradigm Biopharmaceuticals Days Payable Chart

Paradigm Biopharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

13,706.71

15,732.57

184,507.50

Paradigm Biopharmaceuticals Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial												24,352.80	25,966.89	259,223.00	226,625.89	-

Competitive Comparison of Paradigm Biopharmaceuticals's Days Payable

For the Biotechnology subindustry, Paradigm Biopharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paradigm Biopharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Paradigm Biopharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Paradigm Biopharmaceuticals's Days Payable falls into.

Paradigm Biopharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Paradigm Biopharmaceuticals's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (4.981	+	8.162)	/	2 )	/	0.013	*	365
=	6.5715					/	0.013	*	365
=	184,507.50

Paradigm Biopharmaceuticals's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (8.162	+	6.684)	/	2 )	/	0	*	365 / 2
=	7.423					/	0	*	365 / 2
=	N/A

Paradigm Biopharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Paradigm Biopharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Paradigm Biopharmaceuticals (Paradigm Biopharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Paradigm Biopharmaceuticals Ltd (OTCPK:PBIGF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

PAR:Australia

Address

500 Collins Street, Level 15, Melbourne, VIC, AUS, 3000

Website

https://www.paradigmbiopharma.com

Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company that engages in the research and development of therapeutic products for human use in Australia. The firm is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema, Alphavirus - Ross River virus (RRV) and Chikungunya virus (CHIKV), Mucopolysaccharidosis, and allergic respiratory conditions, including allergic rhinitis (AR) and chronic obstructive pulmonary disease (COPD).